文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

乳腺癌患者腋窝逆行标记联合吲哚菁绿荧光成像。

Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer.

机构信息

Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Japan.

出版信息

J Surg Oncol. 2010 Mar 1;101(3):217-21. doi: 10.1002/jso.21473.


DOI:10.1002/jso.21473
PMID:20063370
Abstract

BACKGROUND: The ARM technique was proposed to prevent arm lymphedema after ALND and/or SLN biopsy. However, several problems remain to be resolved in the practical application of this technique. METHODS: The fluorescent ARM nodes and/or lymphatics were identified using a fluorescence imaging system with subdermal injection of indocyanine green into the upper limb. ALND was performed in patients with clinically involved nodes, and the ARM nodes were separately removed during ALND. SLN biopsy was performed in patients with clinically uninvolved nodes. If SLN was positive, ALND was performed with removal of ARM nodes. Otherwise, identified ARM nodes were preserved unless they were the same as SLN. RESULTS: ARM nodes and/or lymphatics were identified in 7 (88%) of 8 patients who underwent ALND, whereas they were identified in 9 (75%) of 12 patients who underwent SLN biopsy alone. ARM nodes were involved with tumors in 3 (43%) of the former patients, and SLN was the same as the ARM node in 2 (14%) of 14 patients who underwent SLN biopsy. CONCLUSIONS: Fluorescence imaging was sensitive for identification of ARM nodes and/or lymphatics. However, further studies are needed before efforts to preserve these nodes can be safely implemented.

摘要

背景:ARM 技术旨在预防 ALND 和/或 SLN 活检后的手臂淋巴水肿。然而,在该技术的实际应用中仍存在一些问题需要解决。

方法:荧光 ARM 节点和/或淋巴管通过在上肢皮内注射吲哚菁绿,使用荧光成像系统进行识别。对于临床有淋巴结受累的患者进行 ALND,并在 ALND 期间单独切除 ARM 淋巴结。对于临床无淋巴结受累的患者进行 SLN 活检。如果 SLN 阳性,则进行 ALND 切除 ARM 淋巴结。否则,除非与 SLN 相同,否则保留已识别的 ARM 淋巴结。

结果:在接受 ALND 的 8 例患者中,有 7 例(88%)识别出了 ARM 淋巴结和/或淋巴管,而在单独接受 SLN 活检的 12 例患者中,有 9 例(75%)识别出了 ARM 淋巴结和/或淋巴管。在前一组患者中,有 3 例(43%)的 ARM 淋巴结与肿瘤有关,在接受 SLN 活检的 14 例患者中,有 2 例(14%)的 SLN 与 ARM 淋巴结相同。

结论:荧光成像对识别 ARM 淋巴结和/或淋巴管具有敏感性。然而,在能够安全实施保存这些淋巴结的努力之前,还需要进一步的研究。

相似文献

[1]
Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer.

J Surg Oncol. 2010-3-1

[2]
Axillary reverse mapping using a fluorescence imaging system in breast cancer.

J Surg Oncol. 2011-9-12

[3]
Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.

J Am Coll Surg. 2008-5

[4]
Axillary reverse mapping for breast cancer.

Breast Cancer Res Treat. 2010-2

[5]
Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.

Ann Surg Oncol. 2013-8-22

[6]
Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.

Eur J Surg Oncol. 2016-5

[7]
Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.

J Clin Oncol. 2009-10-13

[8]
Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.

Eur J Surg Oncol. 2008-2

[9]
Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.

Br J Surg. 2009-11

[10]
Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.

Ann Surg Oncol. 2006-1

引用本文的文献

[1]
Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph Node Dissection in Breast Cancer: The FARM Trial.

Ann Surg Oncol. 2025-6-23

[2]
Quality of life and oncologic safety of axillary reverse mapping in patients with breast cancer: a systematic review and meta-analysis.

Ann Med Surg (Lond). 2025-5-21

[3]
Higher Rates of Visualization for Axillary Reverse Mapping Using Indocyanine Green Fluorescence Compared With Blue Dye.

J Surg Res. 2025-2

[4]
Conservative Axillary Surgery May Prevent Arm Lymphedema without Increasing Axillary Recurrence in the Surgical Management of Breast Cancer.

Cancers (Basel). 2023-11-9

[5]
Axillary Reverse Mapping in Clinically Node-Positive Breast Cancer Patients.

Cancers (Basel). 2023-11-6

[6]
Indo-cyanine green administration to identify loss of lymph after axillary lymph node dissection.

Front Oncol. 2023-3-13

[7]
Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial.

Cancer. 2022-12-15

[8]
Near-Infrared Fluorescence Axillary Reverse Mapping (ARM) Procedure in Invasive Breast Cancer: Relationship between Fluorescence Signal in ARM Lymph Nodes and Clinical Outcomes.

Cancers (Basel). 2022-5-25

[9]
Application of Fluorescence Dye in Combination with Methylene Blue for Axillary Reverse Mapping in Patients with Modified Radical Mastectomy for Breast Cancer.

J Oncol. 2022-5-14

[10]
Comparison of indocyanine green and methylene blue use for axillary reverse mapping during axillary lymph node dissection.

MedComm (2020). 2020-9-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索